Investigational drugs for the treatment of thymic cancer: a focus on phase 1 and 2 clinical trials.

已完结 10 由行止发布于 2026/3/3 23:58:41

DOI:10.1080/13543784.2022.2113373
作者：Fabio Conforti, Laura Pala, Tommaso De Pas, Yongfeng He, Giuseppe Giaccone
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1080/13543784.2022.2113373

Taylor & Francis

Abstract：Introduction: Thymic epithelial tumors (TETs) are rare tumors of thymic epithelial cells. Treatment options for advanced disease patients who failed standard platinum-based chemotherapy are

应助信息

12小时前

iwu

3ce47410175b11f18ad034735aa3bc31.pdf 已采纳

19小时前

Book学术机器人

2026/3/3 23:58:41 未找到该文献，机器人已退出，请等待人工下载

2026/3/3 23:58:41 Book学术AI机器人收到请求，开始寻找文献

2026/3/3 23:58:41 已向机器人发送请求

19小时前

行止发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:SageChemotherapy with carboplatin and paclitaxel after failure of primary chemotherapy for advanced thymic carcinoma. A report of three cases and review of the literature.